首页 > 市场调查报告书 > 医疗设备

导管药物递输设备

市场调查报告书

商品编码

1122421

药物洗脱气球市场：按产品类型、最终用户、地区、市场规模、份额、前景、机会分析，2022-2030

Drug Eluting Balloon Market, by Product Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年08月17日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

药物洗脱球囊是涂有抗增殖药物的血管成形术球囊，当球囊充气至标称压力和指定的最短充气时间时，通常会洗脱到血管壁中。理想的是涂在药物洗脱球囊上的活性物质是亲脂性的，具有从血管壁的高吸收率。紫杉醇因其对血管壁的高药代动力学渗透性而主要用作活性成分，并在美国市场积极用于药物洗脱球囊，并且已在欧洲获批使用增加。药物涂层球囊 (DCB)，也称为药物洗脱球囊 (DEB)，是作为一种控制外周血管再狭窄率的方法而开发的。它还正在进行临床试验，以防止冠状动脉支架内再狭窄。球囊含有一种抗增殖药物，当球囊扩张时，该药物会输送到血管壁。在用球囊血管成形术治疗动脉粥样硬化病变时，这种药物有助于防止血管段创伤引起的新内膜增生（疤痕组织的生长）。 DCB可用于治疗因定期穿刺而反復损伤血管的透析患者的动静脉通路瘘管增生。 DCB 还用于治疗因支架内瘢痕组织生长而导致的支架内再狭窄，这可能导致血管闭塞。与保守治疗相比，经皮冠状动脉介入治疗的血管成形术已显示出令人满意的结果。

市场动态

市场上主要参与者不断推出的产品预计将推动全球药物洗脱球囊市场的增长。例如，2019 年 10 月，健康技术公司 Koninklijke Philips N.V. 推出了两种新的 Stellarex 药物涂层气球尺寸。皇家飞利浦在其 Stellarex 0.035 英寸低剂量药物涂层球囊 (DCB) 产品组合中推出了两款新球囊。新的 200 毫米和 150 毫米 Stellax 0.035 英寸低剂量 DCB 已获得美国食品和药物管理局 (FDA) 的批准，用于治疗上肢股骨或腘动脉浅表动脉的肿瘤性和再狭窄病变。新球囊扩展了 Stellarex 的产品组合，为医生提供更多的治疗选择，用于再狭窄高风险的外周动脉疾病 (PAD) 患者。

本研究的主要特点

本报告对全球药物洗脱球囊市场进行了深入分析，提供了以 2021 年为基准年的预测期间（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。我在这里。
它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
它还提供有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
根据公司亮点、产品组合、关键亮点、财务业绩和战略等参数，介绍了全球药物洗脱球囊市场主要参与者的概况。
本研究涵盖的主要公司包括 Medtronic、Becton、Dickinson and Company (BD)、Boston Scientific Corporation、Cook Medical、B. Braun Melsungen AG、Koninklijke Philips N.V.、Opto Circuits (India) Limited、Terumo Corporation、 Surmodics, Inc. 和 Biotronik。
本报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
本研究报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
利益相关者可以通过用于分析全球药物洗脱球囊市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写说明

第二章市场展望

举报内容
- 市场定义和范围
执行摘要
- 按产品类型划分的市场概况
- 市场快照：按最终用户分类
- 市场概况：按地区划分
连贯的机会图 (COM)

第 3 章市场动态、监管和趋势分析

市场动态
- 驱动程序
- 约束因素
- 市场机会
市场趋势
影响分析
主要亮点
PEST 分析
PORTER 分析
併购
流行病学

第 4 章全球药物洗脱气球市场 - 冠状病毒 (COVID-19) 大流行的影响

整体影响
政府举措
COVID-19 对市场的影响

第 5 章全球药物洗脱球囊市场，按产品类型，2017-2030 年

用于冠状动脉的药物洗脱球囊
外周药物洗脱球囊
其他

第 6 章全球药物洗脱气球市场：按最终用户分类，2017-2030 年

医院
CATH 实验室
门诊手术中心
其他

第 7 章全球药物洗脱球囊市场，按地区，2017-2030 年

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地区
欧洲
英国
德国
意大利
法国
西班牙
俄罗斯
其他欧洲
亚太地区
中国
印度
日本
东盟
澳大利亚
韩国
其他亚太地区
中东
海合会
以色列
其他中东
非洲
北非
中非
南非

第 8 章竞争格局

热图分析
市场份额分析
公司简介
- Medtronic
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cook Medical
- B. Braun Melsungen AG
- Koninklijke Philips N.V.
- Opto Circuits（India）Limited
- Terumo Corporation
- Surmodics, Inc.
- Biotronik

第九章章节

调查方法介绍
关于出版商

简介目录

Product Code: CMI2459

Drug eluting balloons are angioplasty balloons that are coated with an anti-proliferative drug, which is eluted in vessel walls during the inflation of balloon, usually at nominal pressure with a specific minimal inflation time. The active substance coated on the drug eluting balloon should be lipophilic in nature to have a high absorption rate through the vessel wall. Mostly paclitaxel is used as active ingredient due to its high pharmacokinetic transfer rate into the vessel wall and it is actively used in drug eluting balloons in the U.S. market and has been already approved for use in Europe. Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels. They also have been investigated in clinical trials to prevent coronary artery in-stent restenosis. The balloons carry an antiproliferative drug that is delivered to the wall of arteries when the balloon is expanded. The drug helps prevent neointimal hyperplasia (scar tissue growth) caused by trauma when the vessel segment is treated for atherosclerotic lesions with balloon angioplasty. DCBs can be used to treat hyperplasia in arteriovenous (AV) access fistulae in dialysis patients, where the vessel undergoes repeated trauma from regular punctures. DCBs are also used to treat in-stent restenosis due to scar tissue proliferation inside stents, which can cause a vessel to occlude. Angioplasty using percutaneous coronary intervention techniques revealed satisfying result compared to conservative medical treatment.

Market Dynamics

Increasing product launches by key players in market are expected to drive the global drug eluting balloon market growth. For instance, in October 2019, Koninklijke Philips N.V., a health technology company, launched two new Stellarex Drug-Coated Balloon Sizes. Royal Philips introduced two new balloons to its Stellarex 0.035" low-dose drug-coated balloon (DCB) portfolio. The new 200mm and 150mm Stellarex 0.035" low-dose DCBs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries, both arteries in the upper leg. The new balloons broadened physicians' treatment options for peripheral artery disease (PAD) patients with a high risk of restenosis and expand the Stellarex portfolio.

Key features of the study:

This report provides an in-depth analysis of the global drug eluting balloon market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global drug eluting balloon market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug eluting balloon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug eluting balloon market

Detailed Segmentation:

Global Drug Eluting Balloon Market, By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
Global Drug Eluting Balloon Market, By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgical Centres
- Others
Global Drug Eluting Balloon Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Medtronic *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cook Medical
- Braun Melsungen AG
- Koninklijke Philips N.V.
- Opto Circuits (India) Limited
- Terumo Corporation
- Surmodics, Inc.
- Biotronik

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Market Trends
Impact Analysis
Key Highlights
PEST Analysis
PORTER's Analysis
Mergers and Acquisitions
Epidemiology

4. Global Drug Eluting Balloon Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Drug Eluting Balloon Market, By Product Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Coronary Drug Eluting Balloon
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Peripheral Drug Eluting Balloon
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Drug Eluting Balloon Market, By End User, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
CATH Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Drug Eluting Balloon Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa